French biopharmaceutical firm Ipsen (IPSEY) has announced the commencement of a share buy-back program to support its employee share allocation plan and employee share plan.
The company has engaged an investment services provider to acquire up to 400,000 Ipsen shares, representing approximately 0.47% of the share capital, over a period not exceeding six months.
This initiative follows the authorization granted during the Company's Annual General Meeting, which took place on 28 May 2024.
